. Author manuscript; available in PMC: 2023 Oct 1.

Published in final edited form as: Acta Neuropathol. 2022 Aug 26;144(4):677–690. doi: 10.1007/s00401-022-02476-7

Table 1.

Incubation period and attack rates

Sample	All mice		Female mice		Male mice		P value
	Incubation period Avg ± SD (dpi^a)	n/n₀^b	Incubation period Avg ± SD (dpi^a)	n/n₀^b	Incubation period Avg ± SD (dpi^a)	n/n₀^b
C9	> 475	0/8	n.d.		n.d.
C17	> 475	0/8	n.d.		n.d.
WT PFFs	210 ± 37	7/7	n.d.		n.d.
MSA5	263 ± 93	14/15	227 ± 86	8/8	311 ± 85	6/7	0.08
MSA6	247 ± 109	16/16	205 ±108	8/8	290 ± 98	8/8	0.31
MSA13	289 ± 88	14/16	253 ± 75	8/8	302 ± 52	6/8	0.18
MSA14	287 ± 99	11/15	258 ± 101	6/7	280 ± 49	5/8	0.20
MSA16	363 ± 117	12/16	275 ± 96	7/9	406 ± 67	5/7	0.13
MSA17	323 ± 79	14/16	306 ± 88	8/8	344 ± 67	6/8	0.65
MSA (all)	281 ± 93	81/94	254 ± 93	45/48	317 ± 80	36/46	0.0005

n.d. not done

Days postinfection

Number of symptomatic animals (n)/number of mice inoculated (n₀)